
Virginia Moves Closer to Legal Cannabis Sales After House, Senate Votes
Competing bills advance despite key differences on licensing and local control
Virginia's House and Senate each passed separate bills this week to establish a regulated adult-use cannabis market, marking the most significant legislative progress since the state legalized possession in 2021.
The competing measures now head to conference committee, where lawmakers will need to reconcile substantial differences on licensing structure, local government authority, and social equity provisions before sending a final version to Governor Glenn Youngkin's desk.
"We've been in limbo for three years," said Delegate Paul Krizek, a key proponent of the House bill. "Virginians can possess cannabis but have no legal way to buy it. That needs to change."
Virginia legalized simple possession and home cultivation in July 2021, but lawmakers failed to agree on a regulatory framework for commercial sales. The resulting legal gray area has frustrated both advocates and law enforcement while allowing illicit markets to flourish.
The Competing Approaches
The House version, which passed 52-46, would create a state-run wholesale system similar to Virginia's alcohol model. Licensed private retailers would purchase cannabis from state-controlled distribution centers, with the state taking a larger cut of revenue.
The Senate bill, approved 21-19, takes a different approach. It would allow fully private supply chains with state oversight but no direct involvement in distribution. The measure also grants localities more authority to regulate or ban cannabis businesses within their jurisdictions.
Both bills include provisions for social equity applicants—individuals from communities disproportionately impacted by cannabis prohibition. But they differ on implementation. The Senate version reserves 30% of licenses for social equity applicants and provides low-interest loans. The House bill sets a 40% goal but lacks dedicated funding mechanisms.
The Revenue Question
Projected tax revenue varies widely between the proposals. The Joint Legislative Audit and Review Commission estimates the House's state-run model could generate $300 million annually within five years. The Senate's private model projects $180-220 million over the same period.
Both bills propose a 21% excise tax on retail sales, on top of the state's 5.3% sales tax. Medical cannabis patients would pay reduced rates under either framework.
"The revenue projections assume we're not losing customers to the illicit market," noted Jenn Michelle Pedini, executive director of Virginia NORML. "If we overtax or overregulate, people will continue buying from unlicensed sources."
What Happens Next
The conference committee has until the legislative session ends March 15 to produce a compromise bill. If successful, the measure would still require Governor Youngkin's signature—and his position remains unclear.
Youngkin has previously expressed concerns about youth access and impaired driving. His administration has not taken a public stance on either current bill.
Industry observers expect the final framework, if enacted, wouldn't launch sales until late 2026 or early 2027. State agencies would need at least 18 months to develop regulations, accept applications, and conduct inspections.
Meanwhile, neighboring Maryland began adult-use sales in July 2023, and Washington D.C. has operated a quasi-legal "gifting" market for years. Some Virginia lawmakers argue the state is losing tax revenue and ceding market share to surrounding jurisdictions.
"Every day we delay is another day Virginia residents spend money in Maryland or D.C.," Krizek said. "It's time to get this done."
The conference committee is expected to begin negotiations next week.
This article is based on original reporting by www.forbes.com.
Original Source
This article is based on reporting from Forbes.
Read the original articleOriginal title: "Virginia Lawmakers Advance Bills To Launch Regulated Cannabis Sales"
Related Topics
Related Stories
LegislationConnecticut Expands Psychedelics Pilot as FDA Decision Looms
Connecticut's Joint Committee on Public Health advanced legislation expanding the state's psychedelic therapy pilot program to include first responders, as lawmakers prepare for potential FDA approval of MDMA and psilocybin treatments.
LegislationRescheduling Won't Fix Cannabis Industry Without Insurance Access
Cannabis industry experts argue Trump's rescheduling order won't stabilize the market without insurance reimbursement access, which matters more than tax relief for long-term viability.
LegislationVirginia Moves Closer to Legal Cannabis Sales as Bills Advance
Virginia's House and Senate advanced companion bills to legalize cannabis sales, moving the legislation closer to Governor Youngkin's desk despite his previous opposition.
More from David Okonkwo
View all articles
Connecticut Expands Psychedelics Pilot as FDA Decision Looms

California Cannabis Packaging Rules Face Industry Scrutiny

Maryland Senate Votes to Extend Psychedelics Task Force to 2027

